Point of care creatinine and eGFR shows accuracy and could help reduce contrast-induced acute kidney injury

Nova Biomedical’s StatSensor^® Creatinine is a handheld analyzer with a miniaturized disposable biosensor for whole blood creatinine testing in point of care settings. Creatinine and eGFR results in 30 seconds can help to minimize the risk of contrast induced nephropathy (CIN) in radiology and cardiac catheterization, to reduce medication risks in oncology and to expedite patient triage and care in emergency departments.

Nova Biomedical’s webinar series include presentations of having creatinine and eGFR results available without a delay when treating patients. Dr. Thomas Keeble has investigated improving patient treatment choices with immediately available creatinine result for STEMI patients and Dr. Sean Currin found StatSensor Creatinine/eGFR more accurate than laboratory Jaffe Creatinine/eGFR method. Learn more from the webinar links below:

• Can Point-of-Care Creatinine Testing Reduce Contrast-Induced Acute Kidney Injury (CI-AKI) in STEMI Patients Treated with PPCI?
  Webinar presentation by Thomas Keeble, MD, MBBS, BSc, MRCP,
  Consultant Cardiologist, Southend Hospital/Essex Cardiothoracic Centre
  Senior Clinical Fellow, PMI Anglia Ruskin University.

• Comparing the Accuracy of POC Creatinine/eGFR vs. Measured GFR for Evaluating Kidney Disease
  Webinar presentation by Dr. Sean Currin
  Department of Chemical Pathology
  University of Witwatersrand and National Health Laboratory Service
  Charlotte Mazeke Johannesburg Academic Hospital
  Johannesburg, South Africa.

Aidian is the proud distributor of Nova Biomedical's StatSensor handheld meters in the Nordics. Read more about the StatStensor Creatinine meter from StatStensor Creatinine product site.